Mural Oncology Plc
(MURA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | |
| Operating Expenses | 138,262 | 196,238 | 184,923 |
| Operating Income | -138,262 | -196,238 | -184,923 |
| Other Income | 9,748 | 951 | 0 |
| Pre-tax Income | -128,514 | -195,287 | -184,923 |
| Income Tax | N/A | 12,160 | 4,884 |
| Net Income Continuous | -128,514 | -207,447 | -189,807 |
| Net Income | $-128,514 | $-207,447 | $-189,807 |
| EPS Basic Total Ops | -7.58 | -12.43 | -11.37 |
| EPS Basic Continuous Ops | -7.58 | -12.43 | -11.37 |
| EPS Diluted Total Ops | -7.58 | -12.43 | -11.37 |
| EPS Diluted Continuous Ops | -7.58 | -12.43 | -11.37 |
| EPS Diluted Before Non-Recurring Items | -7.58 | -12.43 | N/A |
| EBITDA(a) | $-134,750 | $-193,671 | $-183,383 |